Digipharm:
Digipharm aims is to make use of modern blockchain knowledge to triumph over barriers to
Tolerant access and modern pricing, diminish costs for all stakeholders, and avoid
Infrastructural boundaries to constrain value enhancement incentivize innovation and further
The renovation to adapted healthcare.
Personalized medicine:
As the fields of diagnostics, molecular remedy and data capture methods develop over time,
It is expected that customized or embattled therapy will become pervasive across most syndrome areas ushering in a new era of modified healthcare. Such developments will drastically renovate modern business models for investigate and development, dealing pathways and healthcare subsidy. Digipharm comprehend the magnitude and inevitability of value-based healthcare, within such an energetic atmosphere; and is steadfast to most important the renovation of modern promote access and compensation practices universal where modified medication becomes the custom and no longer the immunity.
Data security & privacy:
Utilizing blockchain knowledge for Digipharms’ platforms promotes the maturity of a
Decentralized health sequence communications that is ubiquitous, crystal clear and security
Mindful. In May 2017, The National Health Service (NHS) in the UK was subject to one of the biggest liberate ware attacks in history, crippling almost 50 NHS trusts, parting private data at jeopardy and the stop of frequent services which only added to the calamity of patients. Such vulnerabilities of the current IT infrastructure could be mitigated by the use of an additional layer of unchallengeable, decentralized, cryptographically encrypted platforms that are able to bypass single points of collapse and maintain implementation as normal. Channels of data transmit and communiqué from vacant health in turn systems to Digipharms’ platforms will profit from this additional layer of security.
The requirement for innovative pricing solutions:
When narrative therapies enter the market following authoritarian approval (e.g. Food and Drug supervision in the USA or European Medicines Agency in Europe) they are required to prove that they are a cost-effective use of healthcare resources, often evaluated by a formal or informal health technology assessment (HTA) process. HTA plays an essential role in supporting policy decision-making and has provided a means by which healthcare systems attempt to manage their drugs budget. Tightening healthcare budgets and ever increasing burden on health systems means that payers are less willing to carry the ‘risk’ or ‘uncertainty’ of purchasing and providing costly therapy which is only backed by clinical trial data, where patients are carefully selected under strict entry criteria and often regarded as the ‘healthiest’ among their peers. Novel therapies are substantially unproven among a greater number of patients at day-to-day clinical level, where the criteria for receiving these therapies are less strict than clinical studies and are usually affected by greater compliance issues. It is important to note that cohorts of patients that are enrolled in clinical trials typically have considerable variations in baseline characteristics and even greater variability in socio-demographic characteristics.
Types of innovative pricing solutions:
There is uncertainty or concerns over the drug’s efficacy in a real world setting.
Where potential consumption volumes or the incremental cost of drug compared
To the current standard of care is significant and the potential impact on the health
System’s budget is too large.
When the market for a drug is competitive and several therapies are competing for market share.
A drug may have multiple uses and may provide different amounts of benefit for patients. In such cases, paying the same price for the drug in all uses does not reflect
‘ Value for money’.
FOR Further Information Visit
Official Website: https://www.digipharm.ch/
Whitepaper: https://digipharm.ch/docs/DigipharmWP.pdf
Official Facebook Page: https://www.facebook.com/digipharmteam/
Twitter Page: https://twitter.com/DigipharmTeam
Official Telegram: https://t.me/joinchat/ExOHxk-TuOplQDbBWXaLaQ
Authorized by
Luckyji
https://bitcointalk.org/index.php?action=profile;u=1754163